Showing 81-100 of 511 for: Cochrane Systematic Reviews > Infectious disease 
- Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization
Cochrane Systematic Reviews, 17-Jun-2008
Eradication strategies for methicillin-resistant Staphylococcus aureus (MRSA) are variable. We sought to summarize the evidence for use of antimicrobial agents to eradicate MRSA.
- Antimicrobials for treating symptomatic non‐typhoidal Salmonella infection
Cochrane Systematic Reviews, 14-Nov-2012
Non-typhoidal Salmonella (NTS) commonly causes diarrhoea, and is usually self-limiting, although sometimes people become ill with sepsis and dehydration. Routine antibiotic use for this infection could result in persistent colonization and the spread of r
- Antipyretic measures for treating fever in malaria
Cochrane Systematic Reviews, 12-Sep-2012
Fever is common in malaria, and drugs and sponging are widely used for symptomatic relief. Some researchers have suggested that fever reduction may prolong malaria illness.
- Antiretroviral post‐exposure prophylaxis (PEP) for occupational HIV exposure
Cochrane Systematic Reviews, 24-Jan-2007
Populations such as healthcare workers (HCWs), injection drug users (IDUs), and people engaging in unprotected sex are all at risk of being infected with the human immunodeficiency virus (HIV). Animal models show that after initial exposure, HIV replicate
- Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
Cochrane Systematic Reviews, 19-Jan-2011
Highly active antiretroviral therapy has reduced the morbidity and mortality of patients with HIV/AIDS. A common first-line ART regimen in low-resource settings includes a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse t
- Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
Cochrane Systematic Reviews, 5-May-2010
This systematic review focuses on antiretroviral therapy (ART) for treating human immunodeficiency virus (HIV) infection in ART-eligible pregnant women. Mother-to-child transmission (MTCT) is the primary means by which children worldwide acquire HIV infec
- Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
Cochrane Systematic Reviews, 26-Mar-2013
Antiretroviral drugs have been shown to reduce risk of mother-to-child transmission of human immunodeficiency virus (HIV) and are also widely used for post-exposure prophylaxis for parenteral and sexual exposures. Sexual transmission may be lower in coupl
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
Cochrane Systematic Reviews, 13-Jun-2011
Antiretroviral drugs reduce viral replication and can reduce mother-to-child transmission of HIV either by lowering plasma viral load in pregnant women or through post-exposure prophylaxis in their newborns. In rich countries, highly active antiretroviral
- Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants
Cochrane Systematic Reviews, 15-Apr-2009
Nosocomial infection is a major problem affecting the immediate health and long-term outcome of preterm and very low birth weight neonates. More than half of these infections are caused by staphylococci. Various type specific antibodies targeted at differ
- Antithrombotic drugs for carotid artery dissection
Cochrane Systematic Reviews, 6-Mar-2011
Extracranial internal carotid artery dissection (eICAD) is a leading cause of stroke in younger patients.
- Antiviral agents for treatment of herpes simplex virus infection in neonates
Cochrane Systematic Reviews, 8-Jul-2009
Herpes simplex virus (HSV) is a rare but serious neonatal pathogen. Prior to the availability of antiviral drugs the mortality associated with all but localised neonatal infection was high, with 85% of infants with disseminated HSV infection and 50% of in
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Cochrane Systematic Reviews, 10-Jan-2013
The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients has resulted in the frequent use of prophylaxis with the aim of preventing the clinical syndrome associated with CMV infection. This is an update of a review first published
- Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis
Cochrane Systematic Reviews, 9-Jan-2015
Eye disease due to herpes simplex virus (HSV) commonly presents as epithelial keratitis which, though usually self-limiting, may persist or progress without treatment.
- Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria
Cochrane Systematic Reviews, 11-Aug-2008
The World Health Organization recommends artemether-lumefantrine, an expensive drug, as a treatment for uncomplicated malaria. We sought evidence of the superiority of the four-dose regimen over existing treatments.
- Artemether‐lumefantrine (six‐dose regimen) for treating uncomplicated falciparum malaria
Cochrane Systematic Reviews, 19-Oct-2005
Using a pilot system we have categorised this review as: Current question - no update intended (topic covered in another review. Refer to: Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated
- Artemisinin derivatives for treating severe malaria
Cochrane Systematic Reviews, 27-Jul-1998
Artemisinin derivatives may have advantages over quinoline drugs for treating severe malaria since they are fast acting and effective against quinine resistant malaria parasites.
- Artemisinin derivatives for treating uncomplicated malaria
Cochrane Systematic Reviews, 26-Apr-1999
Artemisinin derivatives are a relatively new group of drugs with antimalarial properties. As resistance to other antimalarial drugs continues to increase, artemisinin drugs may be useful alternatives.
- Artemisinin‐based combination therapy for treating uncomplicated malaria
Cochrane Systematic Reviews, 8-Jul-2009
The World Health Organization recommends uncomplicated P. falciparum malaria is treated using Artemisinin-based Combination Therapy (ACT). This review aims to assist the decision making of malaria control programmes by providing an overview of the relativ
- Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria
Cochrane Systematic Reviews, 9-Oct-2013
Plasmodium vivax is an important cause of malaria in many parts of Asia and South America, and parasite resistance to the standard treatment (chloroquine) is now high in some parts of Oceania. This review aims to assess the current treatment options in t
- Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria
Cochrane Systematic Reviews, 19-Oct-2005
Using a pilot system we have categorised this review as: “Historical question – no update intended: monotherapy no longer recommended" (see published notes).
